(Q48443502)

11 February 2018

title

Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process? (English)

1 reference

11 February 2018

1 reference

1 reference

S E Pålhagen

1

1 reference

11 February 2018

M Carlsson

2

1 reference

11 February 2018

E Curman

3

1 reference

11 February 2018

J Wålinder

4

1 reference

11 February 2018

A-K Granérus

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

13 February 2008

1 reference

11 February 2018

Acta Neurologica Scandinavica

published in

1 reference

11 February 2018

volume

117

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

295-304

1 reference

11 February 2018

Depression and Parkinson's disease: a review

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Depression in Parkinson's disease: conceptual issues and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Risk factors for depression in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Depression rating scales in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Psychopathological symptoms of depression in Parkinson's disease compared to major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Dissociating apathy and depression in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Apathy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Treatment of depression: time to consider folic acid and vitamin B12

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Homocysteine, folate, methylation, and monoamine metabolism in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2007.00986.X

10.1111/J.1600-0404.2007.00986.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018